CHCT - Community Healthcare Trust Inc

📈 Is growth accelerating? 7 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	2.5% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-49%)	—	3.1% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-37%)	-1.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-121%)	7.9% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+59%)	—	15.8% Good → Good Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+217%)	15.6% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+213%)	15.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+215%)	—	6.7% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+34%)	6.0% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20%)	9.7% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+95%)	15.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+210%)	20.2% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+304%)	24.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+382%)	19.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+286%)	19.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+291%)	19.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+279%)	27.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+454%)	33.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+569%)	38.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+662%)	29.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+494%)	15.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+209%)	17.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+252%)	—	32.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+555%)	38.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+678%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	200.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	133.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	1175.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-19.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-72.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-73.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-63.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	-47.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	N/M	—	5.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-4.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	14.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-9.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	15.8% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	133.3% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	83.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	111.1% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	200.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	20.0% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-33.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	400.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	200.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	300.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-75.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	250.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	87.1% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	60.2% Excellent ↓ Excellent Declining Year-over-year change in net income	687.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-6.2% Weak ↑ Weak Improving Year-over-year change in net income	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-56.6% Weak → Weak Stable Year-over-year change in net income	-59.9% Weak Weak Year-over-year change in net income	-49.9% Weak Weak Year-over-year change in net income	N/M	N/M	—	-38.4% Weak Weak Year-over-year change in net income	17.8% Good Good Year-over-year change in net income	N/M	—	6.0% Fair → Fair Stable Year-over-year change in net income	-2.2% Weak ↓ Weak Declining Year-over-year change in net income	3.9% Caution ↓ Caution Declining Year-over-year change in net income	16.7% Good ↓ Good Declining Year-over-year change in net income	2.7% Caution ↓ Caution Declining Year-over-year change in net income	26.2% Excellent ↓ Excellent Declining Year-over-year change in net income	29.6% Excellent ↓ Excellent Declining Year-over-year change in net income	136.8% Excellent → Excellent Stable Year-over-year change in net income	96.9% Excellent ↓ Excellent Declining Year-over-year change in net income	119.1% Excellent ↑ Excellent Improving Year-over-year change in net income	182.8% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	32.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-14.5% Weak ↓ Weak Declining Year-over-year change in net income	-22.5% Weak ↓ Weak Declining Year-over-year change in net income	44.8% Excellent ↓ Excellent Declining Year-over-year change in net income	245.3% Excellent ↑ Excellent Improving Year-over-year change in net income	418.7% Excellent ↑ Excellent Improving Year-over-year change in net income	105.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-102.3% Weak ↓ Weak Declining Year-over-year change in net income	-45.6% Weak ↓ Weak Declining Year-over-year change in net income	-8.3% Weak Weak Year-over-year change in net income	687.1% Excellent Excellent Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	—	—	—	—	—	—	8.6% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	—	8.4% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	6.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	11.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	13.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	14.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	15.0% Excellent → Excellent Stable Compound annual revenue growth over 3 years	14.9% Good ↓ Good Declining Compound annual revenue growth over 3 years	—	15.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	18.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	20.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	24.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.9% Excellent → Excellent Stable Compound annual revenue growth over 3 years	22.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	23.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	—	27.0% Excellent Excellent Compound annual revenue growth over 3 years	27.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	10.9% Good ↓ Good Declining Compound annual revenue growth over 5 years	—	12.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	14.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	16.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	19.0% Excellent → Excellent Stable Compound annual revenue growth over 5 years	18.0% Excellent → Excellent Stable Compound annual revenue growth over 5 years	17.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	18.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	—	21.3% Excellent Excellent Compound annual revenue growth over 5 years	21.9% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	-6.5% Weak Weak Compound annual EPS growth over 3 years	-37.0% Weak Weak Compound annual EPS growth over 3 years	—	—	-47.7% Weak → Weak Stable Compound annual EPS growth over 3 years	—	-47.7% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-45.0% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-41.5% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	—	-19.4% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-10.6% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-20.6% Weak Weak Compound annual EPS growth over 3 years	8.1% Fair Fair Compound annual EPS growth over 3 years	—	—	20.5% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	32.6% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	51.8% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	—	26.0% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	22.4% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	32.6% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	37.9% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	122.4% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	68.1% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	37.0% Excellent → Excellent Stable Compound annual EPS growth over 3 years	65.1% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	14.5% Good ↓ Good Declining Compound annual EPS growth over 3 years	31.0% Excellent Excellent Compound annual EPS growth over 3 years	44.2% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Profit Margin (%) (%)	—	—	—	—	—	—	5.3% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	—	5.9% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-76%)	-37.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-252%)	12.5% Fair ↓ Fair Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-50%)	15.7% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-37%)	12.2% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-51%)	23.6% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-5%)	-25.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-202%)	—	22.9% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	23.2% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-7%)	23.5% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-6%)	26.3% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+5%)	23.0% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-8%)	25.2% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	24.8% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	26.0% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	26.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+8%)	24.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	22.9% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-9%)	13.1% Fair → Fair Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-47%)	16.3% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-35%)	14.4% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-42%)	10.8% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-57%)	-15.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-162%)	15.9% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-36%)	19.5% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-22%)	16.4% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-34%)	—	6.1% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-75%)	5.2% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	—	—	—	—	—	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Capital (%) (%)	0.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	0.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	1.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	0.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-91%)	0.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	0.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-92%)	3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-58%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	-2.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	0.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-95%)	-2.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	0.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-91%)	—	0.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-92%)	1.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	-1.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	—	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	—	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	1.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	1.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	1.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	1.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-86%)	0.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-92%)	0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-89%)	0.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-91%)	0.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-93%)	-0.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-109%)	—	—	—	-1.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-115%)	—	—	0.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	—	—	—	0.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Debt to Equity (x)	1.35x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+35%)	1.35x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+35%)	1.33x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+33%)	1.24x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+24%)	1.24x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+24%)	1.14x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+14%)	1.08x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+8%)	1.02x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.99x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.92x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-8%)	0.86x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-14%)	—	0.77x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-23%)	0.73x Fair → Fair Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-27%)	0.74x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-26%)	0.71x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.65x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.62x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	0.57x Good → Good Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	—	0.56x Good → Good Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-44%)	0.57x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	0.58x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-42%)	—	0.44x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-56%)	0.51x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-49%)	0.55x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-45%)	—	0.72x Fair → Fair Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-28%)	0.71x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-29%)	0.66x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-34%)	—	—	—	—	0.33x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—	0.26x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	—	—	—	—	—
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$557.03M	$556.65M	$556.64M	$528.86M	$526.75M	$495.21M	$493.75M	$481.57M	$470.88M	$456.89M	$438.51M	—	$397.31M	$365.50M	$361.39M	$341.76M	$308.12M	$290.03M	$268.49M	—	$255.92M	$253.72M	$254.84M	—	$167.18M	$192.41M	$199.95M	—	$213.74M	$189.15M	$175.25M	—	—	—	—	$91.22M	$-17.48M	$-831.00K	$48.98M	—	$-1.74M	$-10.92M	$-2.00K	$0.00
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	$1.13	—	$1.11	$1.04	$1.12	—	$1.13	$1.11	$1.12	—	$1.05	$1.02	$1.00	—	$0.99	$0.98	$0.94	—	$0.88	$0.86	$0.87	—	$0.86	$0.78	$0.75	—	$0.71	$0.71	$0.65	—	$0.58	$0.70	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.09	$0.06	$0.07	$0.51	$0.03	$-0.50	$0.03	$0.04	$0.04	$-0.42	$0.11	$0.15	$0.11	$0.24	$-0.32	—	$0.21	$0.21	$0.21	$0.24	$0.20	$0.22	$0.21	$0.21	$0.22	$0.19	$0.18	$0.09	$0.12	$0.09	$0.06	$-0.12	$0.10	$0.12	$0.09	$0.08	$0.02	$0.04	$0.07	$0.02	$0.08	$0.04	$0.02	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$0.33	$0.48	$0.48	$0.48	$0.47	$0.47	$0.47	$0.47	$0.46	$0.46	$0.46	$0.45	$0.45	$0.45	$0.45	$0.44	$0.44	—	—	$0.44	—	—	—	$0.43	—	—	—	$0.42	—	—	—	$0.41	—	—	—	$0.40	$0.39	$0.39	$0.39	$0.39	$0.38	$0.38	$0.38	—
Book Value per Share (USD)	$14.39	$14.46	$14.75	$15.08	$14.99	$15.43	$16.28	$16.85	$16.90	$17.75	$18.47	—	$19.16	$19.04	$18.82	$19.18	$18.91	$18.84	$18.79	—	$18.48	$18.51	$18.43	$18.00	$17.50	$17.03	$16.62	$16.51	$14.91	$14.39	$14.30	$14.58	—	—	—	$15.67	—	—	$25.54	—	—	—	$597.97	—
Tangible Book Value per Share (USD)	$14.39	$14.46	$14.75	$15.08	$14.99	$15.43	$16.28	$16.85	$16.90	$17.75	$18.47	—	$19.16	$19.04	$18.82	$19.18	$18.91	$18.84	$18.79	—	$18.48	$18.51	$18.43	$18.00	$17.50	$17.03	$16.62	$16.51	$14.91	$14.39	$14.30	$14.58	—	—	—	$15.67	—	—	$25.54	—	—	—	$597.97	—
Basic Weighted Avg Shares (shares)	27.07M	27.02M	26.99M	—	26.93M	26.80M	26.73M	—	26.66M	26.48M	26.30M	—	25.51M	25.07M	24.23M	—	23.59M	23.58M	23.57M	—	23.47M	23.20M	22.81M	—	21.87M	21.26M	20.73M	—	18.83M	18.25M	17.95M	—	17.67M	17.57M	17.57M	—	16.24M	12.69M	12.69M	—	12.69M	12.04M	7.51M	—
Dividend Payout Ratio (%)	366.7% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	800.0% Weak → Weak Stable Dividends paid as a percentage of earnings Optimal: 30-60%	682.1% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	93.1% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	1575.0% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	-94.0% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	1558.3% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	1162.5% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	1156.2% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	303.3% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1962.5% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	975.0% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	553.6% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	—	478.1% Weak ↓ Weak Declining Dividends paid as a percentage of earnings Optimal: 30-60%	950.0% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	1887.5% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
LT Debt (USD)	$558.38M	$559.32M	$559.26M	$532.20M	$530.14M	$500.08M	$496.02M	$485.95M	$473.72M	$457.62M	$442.32M	—	$401.19M	$368.13M	$365.06M	$353.00M	$310.78M	$291.73M	$269.67M	—	$257.56M	$258.50M	$260.45M	—	$179.34M	$197.31M	$203.28M	—	$215.46M	$198.18M	$179.12M	—	—	—	—	$93.35M	—	—	$51.00M	—	—	—	—	—
Total Equity (USD)	$413.44M	$414.24M	$421.34M	$429.39M	$426.82M	$437.82M	$461.32M	$475.96M	$477.15M	$497.77M	$511.65M	—	$522.29M	$505.32M	$494.51M	$496.81M	$478.49M	$472.96M	$471.11M	—	$461.67M	$457.06M	$450.09M	$429.92M	$409.62M	$387.10M	$367.77M	$353.41M	$300.95M	$279.12M	$269.68M	$271.66M	—	—	—	$283.37M	—	—	$194.01M	—	—	—	$119.59M	—

📋 What is driving earnings? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	$30.08M	—	$29.64M	$27.52M	$29.33M	$29.12M	$28.73M	$27.81M	$27.18M	—	$24.81M	$24.05M	$23.48M	$23.24M	$23.25M	$22.69M	$21.39M	$20.12M	$19.34M	$18.28M	$17.94M	$16.83M	$16.26M	$14.32M	$13.44M	$12.19M	$12.54M	$12.40M	$11.43M	—	$9.44M	$8.93M	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$5.89M	$5.42M	$5.42M	—	$4.93M	$4.87M	$5.13M	$-7.73M	$4.66M	$4.39M	$4.00M	$-9.75M	$3.56M	$3.29M	$2.91M	—
Net Income, GAAP (USD)	$3.07M	$2.36M	$2.55M	$14.43M	$1.64M	$-12.56M	$1.59M	$1.83M	$1.75M	$-10.43M	$3.67M	$4.57M	$3.49M	$6.58M	$-6.92M	—	$5.67M	$5.58M	$5.52M	$6.11M	$5.35M	$5.71M	$5.32M	$5.24M	$5.21M	$4.53M	$4.10M	$2.21M	$2.65M	$2.07M	$1.45M	$-1.89M	$2.00M	$2.42M	$1.87M	$-3.41M	$579.00K	$466.00K	$913.00K	$-1.69M	$1.06M	$508.00K	$116.00K	—
Operating Cash Flow (USD)	$13.87M	$17.53M	$13.74M	$15.50M	—	—	$14.41M	$15.66M	—	—	$12.64M	$14.29M	—	—	$12.70M	—	—	—	$14.40M	$14.99M	—	—	$13.49M	$12.57M	—	—	$10.25M	$9.18M	—	—	$7.33M	$6.52M	$4.89M	$7.08M	$5.95M	$-12.39M	$6.56M	$4.25M	$4.55M	$-10.80M	$3.86M	$4.35M	$2.59M	—

🏛️ Sector-Specific 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Mar 1, 2022 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Mar 5, 2021 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Feb 28, 2020 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Mar 1, 2019 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Mar 31, 2017 10-Q ↗	Q4 FY2016 Dec 2, 2016 10-K ↗	Q3 FY2016 Sep 30, 2016 10-Q ↗	Q2 FY2016 Jun 30, 2016 10-Q ↗	Q1 FY2016 Mar 31, 2016 10-Q ↗	Q4 FY2015 Mar 27, 2014 10-K ↗
FFO (approx.) (USD)	—	—	$13.21M	—	$12.54M	$-1.68M	$12.53M	—	$12.68M	$365.00K	$13.93M	—	$14.70M	$15.80M	$2.10M	—	$13.68M	$13.66M	$13.47M	—	$13.17M	$13.25M	$12.54M	—	$11.51M	$10.64M	$10.16M	—	$8.54M	$7.48M	$6.87M	—	$6.93M	$7.29M	$7.00M	$-11.15M	$5.24M	$4.86M	$4.91M	$-11.44M	$4.62M	$3.79M	$3.02M	—
FFO per Share (approx.) (USD)	—	—	$0.49	—	$0.47	$-0.06	$0.47	—	$0.48	$0.01	$0.53	—	$0.58	$0.63	$0.09	—	$0.58	$0.58	$0.57	—	$0.56	$0.57	$0.55	—	$0.53	$0.50	$0.49	—	$0.45	$0.41	$0.38	—	$0.39	$0.41	$0.40	—	$0.32	$0.38	$0.39	—	$0.36	$0.32	$0.40	—

Community Healthcare Trust Inc

Analytical Summary

44-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CHCT with peers